New methods to stop and treat tiny cancer spread

A New Paradigm to Prevent and Treat Micrometastases

NIH-funded research Research Inst Nationwide Children's Hosp · NIH-11019737

This study is looking at a new way to help people with cancer by using gene therapy to keep the immune system constantly fighting tiny clusters of cancer cells in the blood, which could help stop them from spreading and causing more serious problems.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionResearch Inst Nationwide Children's Hosp NIH-funded
Lab location1 site (Columbus, United States)
Project IDNIH-11019737 on NIH RePORTER

What this research studies

This research focuses on preventing and treating micrometastases, which are small clusters of cancer cells that can spread and cause serious health issues. The approach involves using gene therapy to create a continuous immune response against these cells while they are in the bloodstream, aiming to catch them before they establish a protective environment. By maintaining constant pressure on these cancer cells, the research seeks to overcome the limitations of current intermittent therapies that allow cancer cells to survive and develop resistance. Patients may benefit from a more effective treatment strategy that targets cancer spread at its earliest stages.

Who could benefit from this research

Good fit: Ideal candidates for this research are patients diagnosed with solid tumors who may have microscopic metastases at the time of diagnosis.

Not a fit: Patients with non-solid tumors or those who do not have evidence of micrometastases may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for preventing cancer spread, potentially improving survival rates for patients with solid tumors.

How similar studies have performed: While the approach of using gene therapy for continuous immune pressure is innovative, similar strategies have shown promise in other cancer treatments, indicating potential for success.

Where this research is happening

Columbus, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions anti-cancerBreast Cancercancer antigens
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.